ArticleFrontiers in physiology2020

A Scientific Rationale for Using Cystic Fibrosis Transmembrane Conductance Regulator Therapeutics in COVID-19 Patients.

Darcy Lidington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.